Literature DB >> 6335385

Clinical and serological comparison of 17 chronic progressive systemic sclerosis (PSS) and 17 CREST syndrome patients matched for sex, age, and disease duration.

D E Furst, P J Clements, M Saab, M G Sterz, H E Paulus.   

Abstract

This study compares the clinical and serological differences between 17 PSS and 17 carefully matched CREST patients. Patients were matched for sex, age by decade, and, importantly, disease duration (11.2 +/- 9.2 vs. 12.0 +/- 9.3 years). Muscular and skin involvement were greater for the PSS groups (p less than 0.02) and pulmonary involvement was also greater (p less than 0.05), at least for non-smoking PSS patients. On the other hand no clinically significant differences were found between groups for other visceral involvement--including comparisons of gastrointestinal, cardiovascular, and renal involvement. There were also no laboratory differences except in anti-RNP antibody (p less than 0.04).

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6335385      PMCID: PMC1001539          DOI: 10.1136/ard.43.6.794

Source DB:  PubMed          Journal:  Ann Rheum Dis        ISSN: 0003-4967            Impact factor:   19.103


  6 in total

1.  Pulmonary hypertension in systemic sclerosis.

Authors:  E Trell; C Lindström
Journal:  Ann Rheum Dis       Date:  1971-07       Impact factor: 19.103

2.  CRST syndrome. A benign variant of scleroderma.

Authors:  R D Carr; E B Heisel; T D Stevenson
Journal:  Arch Dermatol       Date:  1965-11

3.  Prevalence and clinical correlates of pulmonary arterial hypertension in progressive systemic sclerosis.

Authors:  R G Ungerer; D P Tashkin; D Furst; P J Clements; H Gong; M Bein; J W Smith; N Roberts; W Cabeen
Journal:  Am J Med       Date:  1983-07       Impact factor: 4.965

4.  The CREST syndrome: a distinct serologic entity with anticentromere antibodies.

Authors:  M J Fritzler; T D Kinsella
Journal:  Am J Med       Date:  1980-10       Impact factor: 4.965

5.  Pulmonary hypertension in the CREST syndrome variant of progressive systemic sclerosis (scleroderma).

Authors:  R Salerni; G P Rodnan; D F Leon; J A Shaver
Journal:  Ann Intern Med       Date:  1977-04       Impact factor: 25.391

6.  The 'CREST' syndrome. Comparison with systemic sclerosis (scleroderma).

Authors:  E E Velayos; A T Masi; M B Stevens; L E Shulman
Journal:  Arch Intern Med       Date:  1979-11
  6 in total
  7 in total

1.  A new promising treatment in systemic sclerosis: 5-fluorouracil.

Authors:  J A Casas; C P Subauste; G S Alarcón
Journal:  Ann Rheum Dis       Date:  1987-10       Impact factor: 19.103

2.  Sclerodactyly, CREST syndrome, proximal scleroderma.

Authors:  M Giordano
Journal:  Ann Rheum Dis       Date:  1986-01       Impact factor: 19.103

Review 3.  Scleroderma esophagus.

Authors:  S R Fulp; D O Castell
Journal:  Dysphagia       Date:  1990       Impact factor: 3.438

4.  Dexamethasone pulse therapy in patients of systemic sclerosis: is it a viable proposition? A study from kashmir.

Authors:  Farah Sameem; Iffat Hassan; Qazi Masood Ahmad; Dilshad Khan; Imran Majeed; M A Kamili; Parvaiz A Shah
Journal:  Indian J Dermatol       Date:  2010-10       Impact factor: 1.494

5.  Gastrointestinal Manifestations of Systemic Sclerosis.

Authors:  Isabel M McFarlane; Manjeet S Bhamra; Alexandra Kreps; Sadat Iqbal; Firas Al-Ani; Carla Saladini-Aponte; Christon Grant; Soberjot Singh; Khalid Awwal; Kristaq Koci; Yair Saperstein; Fray M Arroyo-Mercado; Derek B Laskar; Purna Atluri
Journal:  Rheumatology (Sunnyvale)       Date:  2018-03-30

6.  The Unusual Suspect: An Acute Gastric Dilation With Volvulus in a Scleroderma Patient.

Authors:  Anusha Agarwal; Alla Turshudzhyan; Alexander Khamechand; Michael Schuster; Micheal Tadros
Journal:  Cureus       Date:  2022-03-24

7.  Preliminary study of cardiovascular manifestations and cardiac severity scale in 58 patients with systemic sclerosis in iran using the medsger scale.

Authors:  Hadi Poormoghim; Mohamad Ali Poorkarim; Maziar Moradi Lakeh; Behnaz Nozary Heshmati; Simin Almasi; Mojtaba Hakim
Journal:  J Tehran Heart Cent       Date:  2010-02-28
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.